TITLE

The incidence of dyslipidemia (hypertriglyceridemia and hypercholesterolemia) in patients treated with the new generation of antipsychotic drugs compared to conventional therapy

AUTHOR(S)
Sadibašić, Belma; Macić-Džanković, Amra; Šabić, Azra; Torlak, Bajro; Lastrić, Gordana; Ćustović, Amir
PUB. DATE
August 2014
SOURCE
Medicinski Glasnik;Aug2014, Vol. 11 Issue 2, p364
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aim To investigate the incidence of dyslipidemia (hypertriglyceridemia and hypercholesterolemia) in patients treated with antipsychotics of new generation compared to conventional therapy. Methods This retrospective study included 116 chronic psychiatric patients divided into two groups: a test group who were on treatment with antipsychotics of the new generation and a control group who were treated with classical antipsychotics. Laboratory and vital parameters were monitored in a group of patients who were treated with new generation antipsychotics (clozapine, olanzapine, risperidone), as well as in the group of patients who were treated with classical antipsychotics (promazine, levopromazin,haloperidol, fluphenazine). Results Mean triglyceride level in the test group was 3.13 mmol/L, and for the control group, 2.28 mmol/L, while the mean value for cholesterol test group was 6.12 mmol/L, and for the control group, 5.85 mmol/L. The average age of the test group was 49.6 years, while the control group was 51.47 years. There was a statistical significance in triglycerides (p = 0.004), while the cholesterol (p = 0.239) and age (p = 0.356) had no statistical significance in the test group compared to the patients who were treated by the new generation of antipsychotics, and the control group of patients who were treated with antipsychotics. Conclusion Dyslipidemia in the form of hypertriglyceridemia occurs more frequently in patients on therapy with the new generation of antipsychotics compared to patients treated with conventional therapy. Hypercholesterolemia as a form of dyslipidemia had not been proven as significantly frequent during the therapy with new antipsychotics in relation to classical antipsychotic treatment.
ACCESSION #
97339293

 

Related Articles

  • The assessment and management of antipsychotic-associated metabolic disturbances from a psychiatric perspective. Chue, Pierre // Canadian Journal of Psychiatry;Mar2004, Vol. 49 Issue 3, p200 

    Objective: To review the available data on the management of antipsychotic-associated metabolic disturbances from a psychiatric perspective.Method: A literature search was initially conducted using the key words followed by a search of relevant articles, including...

  • Comparison of Efficacy of Intensive versus Mild Pitavastatin Therapy on Lipid and Inflammation Biomarkers in Hypertensive Patients with Dyslipidemia. Yamasaki, Tomohiro; Iwashima, Yoshio; Jesmin, Subrina; Ohta, Yuko; Kusunoki, Hiroshi; Hayashi, Shin-ichiro; Horio, Takeshi; Kawano, Yuhei // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Objective: Intensive as compared to mild statin therapy has been proven to be superior in improving cardiovascular outcome, whereas the effects of intensive statin therapy on inflammation and lipoprotein biomarkers are not well defined. Methods: This study assigned essential hypertensive...

  • Antipsychotic drugs and obesity: is prolactin involved? Baptista, Trino; Lacruz, Anny; Meza, Teraiza; Contreras, Quilianio; Delgado, Carlos; Mejias, Maria A; Hernàndez, Luis; Baptista, T; Lacruz, A; Meza, T; Contreras, Q; Delgado, C; Mejìas, M A; Hernàndez, L // Canadian Journal of Psychiatry;Nov2001, Vol. 46 Issue 9, p829 

    Objectives: To correlate the anthropometric indexes (Body Mass Index [BMI] and Waist-Hip ratio [WHR]) with the serum prolactin levels in a heterogeneous population of patients treated with typical antipsychotic (AP) drugs.Methods: We evaluated BMI, WHR, and fasting...

  • Prevalencia de dislipidemias en los pacientes con lupus eritematoso sistémico en el Hospital Clínico Regional de Concepción. Andrea Galdames, G.; Susana Sabat, A.; Camila Sanhueza, F.; Michelle Vinet, M.; Irene Castro, E. // Revista ANACEM;2011, Vol. 5 Issue 2, p91 

    INTRODUCTION: Systemic lupus erythematosus is considered a cardiovascular risk factor. Dyslipidemia is commonly found in these patients. Corticosteroid therapy promotes lipid abnormalities. HYPOTHESES: Systemic lupus erythematosus patients with hypercholesterolemia, hypertriglyceridemia, or...

  • Relación de dislipidemias y gravedad en preeclampsia. Duarte-Mote, Jesús; Perez-Torres, Carolina; Espinosa-López, Rogelio; Lee Eng-Castro, Víctor; Calvo-Colindres, Jesús; Sánchez-Rojas, Graciela; del Socorro Romero-Figueroa, Maria // Revista Medica del IMSS;sep/oct2014, Vol. 52 Issue 5, p516 

    Background: It has been found that the cholesterol and triglyceride values are higher in preeclampsia than in normal pregnancy, even though it is unclear whether these levels are related to the severity. The aim of this study was to determine the correlation between dyslipidemia and severity in...

  • Review: Chlorpromazine Versus Penfluridol for Schizophrenia. Pich, Jacqueline // Issues in Mental Health Nursing;Sep2018, Vol. 39 Issue 9, p814 

    The article offers information on the chronic and relapsing mental disorder, Schizophrenia. Topics discussed include information on the Front-line treatment to manage the symptoms of schizophrenia which the use of anti-psychotic medications, such as chlorpromazine and penfluridol; discussions on...

  • To reduce niacin flush. Fields, Albert; P.F.C. // Cortlandt Forum;11/25/95, Vol. 8 Issue 11, p87 

    Presents a recommendation for the treatment of hypercholesterolemia and hypertriglyceridemia. Intake of niacin for every two hours; Advice on how to reduce the flush reaction of the niacin.

  • Effectiveness of Anti-Psychotics and Related Drugs in the Huntington French-Speaking Group Cohort. Désaméricq, Gaëlle; Dolbeau, Guillaume; Verny, Christophe; Charles, Perrine; Durr, Alexandra; Youssov, Katia; Simonin, Clémence; Azulay, Jean-Philippe; Tranchant, Christine; Goizet, Cyril; Damier, Philippe; Broussolle, Emmanuel; Demonet, Jean-François; Morgado, Graca; de Langavant, Laurent Cleret; Macquin-Mavier, Isabelle; Bachoud-Lévi, Anne-Catherine; Maison, Patrick // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Purpose: Huntington's disease is a rare condition. Patients are commonly treated with antipsychotics and tetrabenazine. The evidence of their effect on disease progression is limited and no comparative study between these drugs has been conducted. We therefore compared the effectiveness of...

  • Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. Swanson, Jeffrey W.; Swartz, Marvin S.; Van Dorn, Richard A.; Volavka, Jan; Monahan, John; Stroup, T. Scott; McEvoy, Joseph P.; Wagner, H. Ryan; Elbogen, Eric B.; Lieberman, Jeffrey A.; CATIE investigators // British Journal of Psychiatry;Jul2008, Vol. 193 Issue 1, p37 

    Background: Violence is an uncommon but significant problem associated with schizophrenia.Aims: To compare antipsychotic medications in reducing violence among patients with schizophrenia over 6 months, identify prospective predictors of violence and examine the impact...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics